Sony Biotechnology Inc.

Sony Biotechnology Inc., doing business as Sony Corp of America, manufactures and services advanced flow cytometry and cell sorting instrumentation for federal biomedical research agencies as a 100% prime contractor, with no subcontract footprint. The company is a for-profit, foreign-owned parent organization headquartered in San Jose, California, and competes on an unrestricted, full-and-open basis across its federal work — no awards carry set-aside designations.

Sony Biotechnology's federal customer base concentrates narrowly within the Department of Health and Human Services' National Institutes of Health. The top five customers account for 51% of recent awards by count and 51% of combined potential value. The National Cancer Institute dominates with 37 awards valued at $4.7 million combined potential value, followed by the National Institute of Allergy and Infectious Diseases (12 awards, $2.1 million), the National Institute on Drug Abuse (9 awards, $1.8 million), the Food and Drug Administration (9 awards, $989 thousand), and the National Institute on Aging (7 awards, $642 thousand). Outside NIH, Sony places work with the Centers for Disease Control and Prevention Pittsburgh (6 awards, $934 thousand), the Department of Veterans Affairs, the Department of Agriculture's Agricultural Research Service, the U.S. Army Corps of Engineers, and the Air Force Research Laboratory. Across all 31 customer agencies served, HHS accounts for the preponderance of volume and dollars.

Sony's capability portfolio is entirely equipment-centric: the company sells flow cytometry and cell sorting instrumentation (Sony MA900, SH800, ID7000, and LE-SH800G cell sorters; ID7000 spectral flow cytometers; ID7000 spectral analyzers) and provides preventive maintenance, repairs, software updates, parts replacement, and onsite service. Representative prime contracts include a $447,107 delivery of a Sony ID7000 spectral flow cytometer with five lasers to the National Institute of Allergy and Infectious Diseases (September 2024), a $470,722.50 full-spectrum flow cytometer (spectral analyzer) to the USDA Agricultural Research Service (September 2024), a $452,607 Sony ID 7000 spectral flow cytometer to the National Cancer Institute's Vaccine Branch (August 2024), and a $227,369.70 microfluidic-based cell sorter system with comprehensive fluidics control and multiple fluorescence and scatter detection channels to the National Institute of Mental Health (August 2026). Maintenance contracts dominate the recent awards by count — examples include a $152,280 one-year system maintenance agreement with the National Cancer Institute for a Sony MH900 FP cell sorter (July 2026), a $135,360 preventive maintenance and service contract with NCI for the MH900 FP through June 2031 (July 2026), and a $119,475 five-year maintenance agreement with the National Institute of Allergy and Infectious Diseases for a Sony MA900 cell sorter (March 2023). Sony functions as sole-source provider on many maintenance contracts, holding proprietary software, replacement parts, and field-service authority that prevents competitive maintenance alternatives.

Awards per year grew from 7 in 2022 to 18 in 2024, then declined to 3 in 2025 and recovered to 7 in 2026, suggesting volatility rather than sustained trajectory growth. Fourteen awards carrying a combined potential value of $2 million reach ultimate completion within the next twenty-four months and face recompete exposure. The company's federal supply schedule position is minimal — three task orders, totaling $98 thousand, sit on the Federal Supply Schedule GS24F0083N. Work is performed across multiple locations: San Jose, California (headquarters and primary service center); Bethesda, Maryland (NCI and NIH Clinical Center facilities); Rockville, Maryland (NCATS); Baltimore, Maryland (NIA); Palo Alto, California (Veterans Integrated Service Network 21); and foreign locations including Japan for certain equipment deliveries. The company operates under NAICS 811210 (Other Electronic and Precision Equipment Repair and Maintenance) and PSC J066 (Laboratory Equipment and Supplies) for the majority of awards, with 75 awards coded to maintenance/repair of laboratory instruments and 56 to laboratory equipment supply.

Sony Biotechnology is part of a larger Sony corporate structure that includes subsidiaries such as Sony Electronics Inc. (foreign-owned, manufacturer of goods), Sony Dadc US Incorporated, and Convergent Media Systems Corporation. The company's market position in federal biomedical research is narrowly specialized: it sells equipment and maintenance services into NIH-led research agencies with minimal defense or civilian-agency penetration outside HHS and USDA. Recompete activity will concentrate on maintenance renewals, where Sony's single-source status on proprietary equipment provides competitive insulation but also exposes renewal decisions to budget constraints and technology refresh cycles at customer institutes.